Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00955682
What this trial is testing

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 342
Not applicableEnded earlyNCT00465582
What this trial is testing

B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors

Who this might be right for
Meningococcal Infections
University Hospital, Rouen 3,296
Large-scale testing (Phase 3)Study completedNCT01339923
What this trial is testing

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,409
Large-scale testing (Phase 3)Study completedNCT01148524
What this trial is testing

Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 817
Testing effectiveness (Phase 2)Study completedNCT01442675
What this trial is testing

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 834
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Post-approval studies (Phase 4)Study completedNCT03493919
What this trial is testing

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,021
Testing effectiveness (Phase 2)Study completedNCT00721396
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Who this might be right for
Meningococcal Infections
Novartis Vaccines 1,885
Testing effectiveness (Phase 2)Study completedNCT01782066
What this trial is testing

Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines

Who this might be right for
Meningococcal Disease
Leiden University Medical Center 12
Large-scale testing (Phase 3)Looking for participantsNCT07505823
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 1,040
Large-scale testing (Phase 3)Study completedNCT00310674
What this trial is testing

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Who this might be right for
Prevention of Meningococcal Infection
Novartis 150
Testing effectiveness (Phase 2)Study completedNCT00454909
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 873
Large-scale testing (Phase 3)Study completedNCT00463437
What this trial is testing

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Who this might be right for
Hepatitis BAcellular PertussisTetanus+3 more
GlaxoSmithKline 1,437
Large-scale testing (Phase 3)Study completedNCT02446743
What this trial is testing

Combined Study - Phase 3b MenB Long Term Persistence in Adolescents

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 531
Large-scale testing (Phase 3)Study completedNCT02955797
What this trial is testing

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 918
Testing effectiveness (Phase 2)Study completedNCT00381615
What this trial is testing

Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Who this might be right for
Healthy
Novartis Vaccines 147
Not applicableLooking for participantsNCT04664569
What this trial is testing

National Bacterial Meningitis Study in Children and Newborns

Who this might be right for
MeningitisChildren, OnlyPneumococcal Conjugate Vaccine+5 more
Association Clinique Thérapeutique Infantile du val de Marne 10,000
Large-scale testing (Phase 3)Study completedNCT04707391
What this trial is testing

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,250
Large-scale testing (Phase 3)Study completedNCT01478347
What this trial is testing

A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 18
Testing effectiveness (Phase 2)Study completedNCT01367158
What this trial is testing

Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 440
Next Page